Recent Trends in Cardiovascular Disease Mortality in Kazakhstan

Gulnara Junusbekova1, Meiramgul Tundybayeva1, Nazgul Akhtaeva2

  • 1Cardiology Department, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.

Insights

Cardiovascular disease mortality in Kazakhstan decreased overall from 2011-2021, with stronger reductions in males. However, rising trends in 2020-2021 and high mortality among young people indicate a need for improved primary care and public health literacy for cardiovascular disease prevention.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • Cardiovascular diseases (CVD) represent the leading cause of death in Kazakhstan.
  • Healthcare reforms have been implemented to reduce mortality from significant diseases, including CVD.

Purpose of the Study:

  • To analyze the trend of avoidable mortality from cardiovascular diseases (CVD) in Kazakhstan between 2011 and 2021.

Main Methods:

  • Utilized national statistics data on population and mortality rates for specific CVDs (rheumatic heart disease, hypertensive diseases, ischemic heart disease, cerebrovascular diseases) from 2011-2021.
  • Applied joinpoint regression to calculate the average annual percentage change (AAPC) in mortality rates.
  • Calculated crude mortality trends per 100,000 population by gender and age group.

Main Results:

  • Avoidable mortality rates for the four studied CVD groups decreased from 2011-2019, but increased in 2020-2021.
  • Overall avoidable CVD mortality showed a significant decrease (AAPC -6.0%) between 2011-2021.
  • Reductions were more pronounced in males than females for ischemic heart disease, cerebrovascular, and hypertensive diseases, though crude mortality remains high in young individuals.

Conclusions:

  • The decline in avoidable CVD mortality may be linked to policies strengthening primary care for early diagnosis and risk factor detection.
  • Primary healthcare facilities require enhanced efforts in public health literacy, focusing on medication adherence and CVD risk factor management for effective prevention.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
366
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
858
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.3K